Ceritinib

Red

Brand Name(s):

Indication:Anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) in adults

Rationale:1,2,3

Considered:Sep-15

Review Date:Jul-21

Comments:
NICE TA 395 Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer
June 2016